Skip to main content

Table 3 Clinical characteristics of patients treated with PLD for lymphoma

From: High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

Clinical characteristics

 

Number of cases (Percentage)

Gender

Male

72(43.1%)

Female

95(56.9%)

Age

≤60

73(43.7%)

> 60

94(56.3%)

Clinical stage

I-II

77(46.1%)

III-IV

90(53.9%)

ECOG score

< 2

108(64.7%)

≥2

59(35.3%)

IPI score

1–2

94(56.3%)

3–5

73(43.7%)

Whether there are large tumor masses

Yes

28(16.8%)

No

139(83.2%)

Pathological type

HL

24(14.4%)

NHL

143(85.6%)

Group B symptoms

Yes

64(38.3%)

No

103(61.7%)

LDH

Normal

65(38.9%)

Elevated

102(61.1%)

History of gallstones

Yes

11(6.6%)

No

156(93.4%)

Viral hepatitis

Yes

23(13.8%)

No

144(86.2%)

  1. *Abbreviations: IPI International Prognostic Index, LDH lactate dehydrogenase